Wealth Enhancement Advisory Services’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$168K Sell
2025
Q2
$77.4K Sell
2025
Q1
$44.1K Sell
2024
Q4
$66.4K Buy
2024
Q3
$96.5K Buy
2024
Q2
$78.9K Buy
2024
Q1
$44.5K Hold
2023
Q4
$30.9K Hold
2023
Q3
$35.8K Buy